The erythropoietin gene polymorphism (rs1617640) is associated with retinopathy in type 2 diabetes patients
Our results demonstrate that in T2DM patients the EPO rs1617460 polymorphism is associated with significantly increased risk of developing DR. This finding can provide a new insight into the role of EPO gene in the pathophysiology of microvascular complications of diabetes.
Authors
- Monika Buraczyńska (ORCID: https://orcid.org/0000-0001-5665-698X)
- Agata Betlejewska (ORCID: https://orcid.org/0000-0002-1464-0493)
- Jolanta Szeliga-Król (ORCID: https://orcid.org/0000-0002-8103-5437)
- Wojciech Zaluska
Institutions
- Medical University of Lublin (PL)
Publication Details
- Journal
- Acta Diabetologica
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1007/s00592-026-02658-9
- Primary Topic
- Erythropoietin and Anemia Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00